Back to today’s briefing

Story perspectives

Psilocybin Shows Promise for Depression, Raises Efficacy Questions

5/13/2025

50 12

Summary

Story summary

A groundbreaking study in the American Journal of Psychiatry reveals that a single dose of psilocybin dramatically alleviated symptoms of severe treatment-resistant depression in 12 participants over 12 weeks. Yet, individuals with posttraumatic stress disorder experienced minimal benefits. While this research showcases psilocybin's promise, the absence of a control group raises important questions about its efficacy.

1 of 1

Story summary

A groundbreaking study in the American Journal of Psychiatry reveals that a single dose of psilocybin dramatically alleviated symptoms of severe treatment-resistant depression in 12 participants over 12 weeks. Yet, individuals with posttraumatic stress disorder experienced minimal benefits. While this research showcases psilocybin's promise, the absence of a control group raises important questions about its efficacy.